{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:27:41Z","timestamp":1772198861063,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100014555","name":"Murdoch Children\u2019s Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014555","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mercy Perinatal Research Fellowship"},{"name":"National Health and Medical Research Council Senior Research Fellowship","award":["10121252"],"award-info":[{"award-number":["10121252"]}]},{"name":"National Health and Medical Research Council Early Career Fellowship","award":["1105603"],"award-info":[{"award-number":["1105603"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What is the frequency of major chromosome abnormalities in a population-based diagnostic data set of genomic tests performed on miscarriage, fetal and infant samples in a state with &amp;gt;73\u2009000 annual births?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>The overall frequency of major chromosome abnormalities in the entire cohort was 28.2% (2493\/8826), with a significant decrease in the detection of major chromosome abnormalities with later developmental stage, from 50.9% to 21.3% to 15.6% of tests in the miscarriage, prenatal and postnatal cohorts, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Over the past decade, technological advances have revolutionized genomic testing at every stage of reproduction. Chromosomal microarrays (CMAs) are now the gold standard of chromosome assessment in prenatal diagnosis and pediatrics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>A population-based cohort study including all chromosome analysis was performed in the Australian state of Victoria during a 24-month period from January 2015 to December 2016. All samples obtained via invasive prenatal diagnosis and postnatal samples from pregnancy tissue and infants \u226412\u00a0months of age were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>A research collaboration of screening and diagnostic units in the Australian state of Victoria was formed (the Perinatal Record Linkage collaboration), capturing all instances of prenatal and postnatal chromosome testing performed in the state. Victoria has over 73\u2009000 births per annum and a median maternal age of 31.5\u00a0years. We analyzed our population-based diagnostic data set for (i) chromosome assessment of miscarriage, prenatal diagnosis and postnatal samples; (ii) testing indications and diagnostic yields for each of these cohorts; (iii) and the combined prenatal\/infant prevalence of 22q11.2 deletion syndrome (DS) as a proportion of all births \u226520\u00a0weeks gestation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>During the 24-month study period, a total of 8826 chromosomal analyses were performed on prenatal and postnatal specimens in Victoria. The vast majority (91.2%) of all chromosome analyses were performed with CMA.<\/jats:p>\n                  <jats:p>The overall frequency of major chromosome abnormalities in the entire cohort was 28.2% (2493\/8826). There was a significant decreasing trend in the percentage of chromosome abnormalities with later developmental stage from 50.9% to 21.3% to 15.6% in the miscarriage, prenatal and postnatal cohorts, respectively (\u03c72 trend\u2009=\u2009790.0, P\u00a0&amp;lt;\u20090.0001). The total frequency of abnormalities in the live infant subgroup was 13.4% (244\/1816). The frequencies of pathogenic copy number variants (CNVs) detected via CMA for the miscarriage, prenatal and postnatal cohorts were 1.9% (50\/2573), 2.2% (82\/3661) and 4.9% (127\/2592), respectively. There was a significant increasing trend in the frequency of pathogenic CNVs with later developmental stage (\u03c72 trend\u2009=\u200939.72, P\u00a0&amp;lt;\u20090.0001). For the subgroup of live infants, the pathogenic CNV frequency on CMA analysis was 6.0% (109\/1816). There were 38 diagnoses of 22q11.2 DS, including 1 miscarriage, 15 prenatal and 22 postnatal cases. After excluding the miscarriage case and accounting for duplicate testing, the estimated prevalence of 22q11 DS was 1 in 4558 Victorian births.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>Clinical information was missing on 11.6% of postnatal samples, and gestational age was rarely provided on the miscarriage specimens. We were unable to obtain rates of termination of pregnancy and stillbirth in our cohort due to incomplete data provided by clinical referrers. We therefore cannot make conclusions on pregnancy or infant outcome following diagnostic testing. Childhood and adult diagnoses of 22q11 DS were not collected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Our study marks a complete transition in genomic testing from the G-banded karyotype era, with CMA now established as the first line investigation for pregnancy losses, fetal diagnosis and newborn\/infant assessment in a high-income setting. Integration of prenatal and postnatal diagnostic data sets provides important opportunities for estimating the prevalence of clinically important congenital syndromes, such as 22q11 DS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>L.H. is funded by a National Health and Medical Research Council Early Career Fellowship (1105603); A.L. was funded by a Mercy Perinatal Research Fellowship; J.H. was funded by a National Health and Medical Research Council Senior Research Fellowship (10121252). The funding bodies had no role in the conduct of the research or the manuscript. Discretionary funding from the Murdoch Children\u2019s Research Institute has supported the prenatal diagnosis data collection and reporting over the years.<\/jats:p>\n                  <jats:p>Dr Ricardo Palma-Dias reports a commercial relationship with Roche Diagnostics, personal fees from Philips Ultrasound, outside the submitted work. Debbie Nisbet reports a commercial relationship with Roche Diagnostics, outside the submitted work.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>NA<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/dez286","type":"journal-article","created":{"date-parts":[[2020,1,4]],"date-time":"2020-01-04T12:09:50Z","timestamp":1578139790000},"page":"694-704","source":"Crossref","is-referenced-by-count":11,"title":["A minimum estimate of the prevalence of 22q11 deletion syndrome and other chromosome abnormalities in a combined prenatal and postnatal cohort"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9720-3562","authenticated-orcid":false,"given":"Lisa","family":"Hui","sequence":"first","affiliation":[{"name":"Reproductive Epidemiology Group, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology, University of Melbourne, Parkville 3052, Victoria, Australia"},{"name":"Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Poulton","sequence":"first","affiliation":[{"name":"Reproductive Epidemiology Group, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza","family":"Kluckow","sequence":"first","affiliation":[{"name":"Reproductive Epidemiology Group, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthea","family":"Lindquist","sequence":"first","affiliation":[{"name":"Reproductive Epidemiology Group, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"},{"name":"Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briohny","family":"Hutchinson","sequence":"first","affiliation":[{"name":"Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D","family":"Pertile","sequence":"first","affiliation":[{"name":"Victorian Clinical Genetics Services, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Bonacquisto","sequence":"first","affiliation":[{"name":"Victorian Clinical Genetics Services, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Gugasyan","sequence":"first","affiliation":[{"name":"Cytogenetics, Monash Pathology, Monash Medical Centre, Clayton 3168, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Kulkarni","sequence":"first","affiliation":[{"name":"Cytogenetics, Monash Pathology, Monash Medical Centre, Clayton 3168, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Harraway","sequence":"first","affiliation":[{"name":"Department of Cytogenetics\/Molecular Pathology, Sullivan Nicolaides Pathology, Bowen Hills, Queensland 4006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Howden","sequence":"first","affiliation":[{"name":"Cytogenetics, Melbourne Pathology, Collingwood 3066, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"McCoy","sequence":"first","affiliation":[{"name":"Molecular Genetics, Australian Clinical Labs, Clayton 3168, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio Da Silva","family":"Costa","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, S\u00e3o Paulo, Brazil"},{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton 3168, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody","family":"Menezes","sequence":"first","affiliation":[{"name":"Monash Ultrasound for Women, Richmond 3121, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Palma-Dias","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Melbourne, Parkville 3052, Victoria, Australia"},{"name":"Women\u2019s Ultrasound Melbourne, East Melbourne 3002, Victoria, Australia"},{"name":"Ultrasound Services, Royal Women\u2019s Hospital, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Nisbet","sequence":"first","affiliation":[{"name":"Women\u2019s Ultrasound Melbourne, East Melbourne 3002, Victoria, Australia"},{"name":"Ultrasound Services, Royal Women\u2019s Hospital, Parkville 3052, Victoria, Australia"},{"name":"Department of Medicine and Radiology, University of Melbourne, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Martin","sequence":"first","affiliation":[{"name":"Virtus Diagnostics and Pathology Services, Spring Hill 4000, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bethune","sequence":"first","affiliation":[{"name":"Specialist Women\u2019s Ultrasound, Box Hill 3128, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeffie","family":"Poulakis","sequence":"first","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, Parkville 3052, Victoria, Australia"},{"name":"Victorian Infant Hearing Screening Program, Centre for Community Child Health, Royal Children\u2019s Hospital, Parkville 3052, Victoria, Australia"},{"name":"Prevention Innovation Group, Population Health, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Halliday","sequence":"first","affiliation":[{"name":"Reproductive Epidemiology Group, Murdoch Children\u2019s Research Institute, Parkville 3052, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Parkville 3052, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"2020033016152193200_ref1","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1097\/AOG.0000000000001817","article-title":"Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Committee Opinion No. 682","volume":"128","author":"American College of Obstetricians and Gynecologists","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2020033016152193200_ref2","author":"Australian Bureau of Statistics","year":"2018"},{"key":"2020033016152193200_ref3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1105043","article-title":"Genomics and perinatal care","volume":"366","author":"Bodurtha","year":"2012","journal-title":"N Engl J Med"},{"key":"2020033016152193200_ref4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1542\/peds.112.1.101","article-title":"A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population","volume":"112","author":"Botto","year":"2003","journal-title":"Pediatrics"},{"key":"2020033016152193200_ref5","author":"Consultative Council on Obstetric and Paediatric Mortality and Morbidity","year":"2017"},{"key":"2020033016152193200_ref6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jmg.35.9.789-a","article-title":"The annual incidence of DiGeorge\/velocardiofacial syndrome","volume":"35","author":"Devriendt","year":"1998","journal-title":"J Med Genet"},{"key":"2020033016152193200_ref7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/adc.79.4.348","article-title":"A population study of chromosome 22q11 deletions in infancy","volume":"79","author":"Goodship","year":"1998","journal-title":"Arch Dis Child"},{"key":"2020033016152193200_ref8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0009922815591090","article-title":"Post-childhood presentation and diagnosis of DiGeorge syndrome","volume":"55","author":"Friedman","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"key":"2020033016152193200_ref9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pd.4613","article-title":"Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"key":"2020033016152193200_ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/uog.15845","article-title":"Cell-free DNA testing for 22q11.2 deletion syndrome: appraising the viability, effectiveness and appropriateness of screening","volume":"47","author":"Hui","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2020033016152193200_ref11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/gim.2017.55","article-title":"Population-based impact of noninvasive prenatal screening (NIPS) on screening and diagnostic testing for fetal aneuploidy","volume":"19","author":"Hui","year":"2017","journal-title":"Genet Med"},{"key":"2020033016152193200_ref12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cge.13098","article-title":"Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions","volume":"93","author":"Martin","year":"2018","journal-title":"Clin Genet"},{"key":"2020033016152193200_ref13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","article-title":"Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies","volume":"86","author":"Miller","year":"2010","journal-title":"Am J Hum Genet"},{"key":"2020033016152193200_ref14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/adc.2003.026880","article-title":"Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden","volume":"89","author":"Oskarsd\u00f3ttir","year":"2004","journal-title":"Arch Dis Child"},{"key":"2020033016152193200_ref15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ajmg.a.38645","article-title":"Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome","volume":"176","author":"Palmer","year":"2018","journal-title":"Am J Med Genet"},{"key":"2020033016152193200_ref16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/humrep\/dey021","article-title":"Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients","volume":"33","author":"Popescu","year":"2018","journal-title":"Hum Reprod"},{"key":"2020033016152193200_ref17","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1201569","article-title":"NICHD Stillbirth Collaborative Research Network. Karyotype versus microarray testing for genetic abnormalities after stillbirth","volume":"367","author":"Reddy","year":"2012","journal-title":"N Engl J Med"},{"key":"2020033016152193200_ref18","author":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists\/Human Genetics Society Australasia","year":"2018"},{"key":"2020033016152193200_ref19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jmg.33.8.719","article-title":"Prevalence of 22q11 microdeletion","volume":"33","author":"Tezenas Du Montcel","year":"1996","journal-title":"J Med Genet"},{"key":"2020033016152193200_ref20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/3\/694\/32981037\/dez286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/3\/694\/32981037\/dez286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T20:16:08Z","timestamp":1585599368000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/3\/694\/5811216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,24]]},"published-print":{"date-parts":[[2020,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dez286","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,3]]}}}